Inter Pharma PCL (BKK:IP)

Inter Pharma PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	278.93	184.6	412.39	776.42	173.87	152.33
Short-Term Investments	0.94	0.93	0.86	0.83	0.8	0.77
Cash & Short-Term Investments	279.87	185.53	413.25	777.25	174.67	153.09
Cash Growth	-9.99%	-55.10%	-46.83%	344.99%	14.09%	-55.34%
Accounts Receivable	337.95	376.06	337.32	340.3	258.11	124.38
Other Receivables	75.09	71.37	87.74	51.89	34.08	31.49
Receivables	413.04	447.43	425.06	392.2	292.25	155.93
Inventory	360.44	339.49	351.82	332.98	192	107.65
Other Current Assets	6.71	9.35	12.72	12.78	7.7	0.61
Total Current Assets	1,060	981.8	1,203	1,515	666.61	417.28
Property, Plant & Equipment	1,184	1,150	929.27	880.77	457.32	255.39
Long-Term Investments	41.74	41.78	43.37	9.35	10.12	-
Goodwill	477.85	477.85	477.85	477.85	22.16	22.16
Other Intangible Assets	207.23	204.46	197.36	167.79	55.1	48.58
Long-Term Deferred Tax Assets	18.17	20.17	15.91	9.81	8.98	3.38
Other Long-Term Assets	150.4	144.42	85.75	29.52	106.76	9.5
Total Assets	3,139	3,021	2,952	3,090	1,327	756.33
Accounts Payable	191.76	184.6	200.52	193.79	69.65	58.49
Accrued Expenses	43.67	46.03	47.06	34.74	15.92	11.69
Short-Term Debt	125.77	79.91	46.34	48.73	131.01	11.01
Current Portion of Long-Term Debt	65.47	55.2	54.43	72.51	35.62	15.53
Current Portion of Leases	31.08	26.64	38.89	30.46	0.57	0.64
Current Income Taxes Payable	13.32	11.84	4.11	25.18	14.8	8.4
Current Unearned Revenue	4.57	4.59	-	-	-	-
Other Current Liabilities	121.94	117.47	87.39	92.55	68.06	54.58
Total Current Liabilities	597.57	526.29	478.75	497.95	335.63	160.35
Long-Term Debt	147.43	167.19	205.46	319.61	187.06	90.91
Long-Term Leases	67.87	65.5	54.83	67.69	1.9	2.47
Long-Term Deferred Tax Liabilities	55.64	58.22	59.21	55.33	3.53	7.62
Other Long-Term Liabilities	11.13	8.32	3.66	2.14	-	-
Total Liabilities	924.77	866.4	834.65	973.86	543.54	269.89
Common Stock	302.67	302.67	186.26	186.26	149.01	103
Additional Paid-In Capital	1,498	1,498	1,498	1,498	492.09	304.98
Retained Earnings	186.57	132.41	225.25	238.26	116.85	58.16
Comprehensive Income & Other	3.7	3.7	3.7	3.7	3.7	3.7
Total Common Equity	1,991	1,937	1,913	1,926	761.64	469.85
Minority Interest	223.49	217.4	204.53	190.25	21.86	16.59
Shareholders' Equity	2,214	2,154	2,118	2,116	783.5	486.44
Total Liabilities & Equity	3,139	3,021	2,952	3,090	1,327	756.33
Total Debt	437.61	394.45	399.95	539	356.17	120.57
Net Cash (Debt)	-157.74	-208.92	13.3	238.25	-181.5	32.53
Net Cash Growth	-	-	-94.42%	-	-	-90.25%
Net Cash Per Share	-0.26	-0.35	0.02	0.45	-0.38	0.07
Filing Date Shares Outstanding	605.34	605.34	605.35	605.35	484.27	468.65
Total Common Shares Outstanding	605.34	605.34	605.35	605.35	484.27	468.65
Working Capital	462.49	455.51	724.1	1,017	330.98	256.93
Book Value Per Share	3.29	3.20	3.16	3.18	1.57	1.00
Tangible Book Value	1,306	1,254	1,238	1,281	684.38	399.11
Tangible Book Value Per Share	2.16	2.07	2.05	2.12	1.41	0.85
Land	-	333.9	327.63	327.63	183.25	117.3
Buildings	-	534.98	430.08	404.55	177.13	66.64
Machinery	-	379.84	346.66	310.51	148.3	105.7
Construction In Progress	-	174.85	57.17	15.97	0.33	1.1

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.